Aimei Health Technology Co., Ltd
NASDAQ:AFJKShell Companies
-$3.66 today
- Market cap
- $73.22M
- Beta
- 0.23
- P/E (TTM)
- 34.3
- EPS (TTM)
- $0.88
Volume 0.13M
Average 0.02M
AFJK Net Income
Bottom-line profit after all expenses, interest, and taxes.
Aimei Health Technology Co., LtdNASDAQ: AFJK
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income declines year over year
Q1 FY2026 net income of $45.44K fell 75.4% year over year, behind the -53.5% change in trailing-twelve-month net income. Sequentially, it fell 53.7% from the prior quarter.
Context
- Net income increased in 1 of the last 2 fiscal years.
What to watch
Whether quarterly growth recovers from -75.4% toward the trailing-twelve-month pace of -53.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Net Income history
USD · from the income statement
- Latest · FY2025
- 1.06M USD
- Year-over-year change
- -58.5%
- 2-year CAGR
- +148.7%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.06M | -58.5% |
| FY2024 | 2024-12-31 | 2.55M | +1389.0% |
| FY2023 | 2023-12-31 | 171.39K | — |
Net Income vs competitors
How AFJK compares with its peers on the latest reported figures
- AFJK's LTM Mar 2026 net income of $920.55K is the 4th highest of the 8 companies compared; the peer median is $586.98K.
- Its year-over-year change of -53.5% is the 2nd highest of 4, against a peer median of -65.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Dec 2025 | $3.89M | +5.0% | +5.1% | 13.1% | |
KOYNCSLM Digital Asset Acquisition Corp III Class A Ordinary Shares | LTM Mar 2026 | $3.22M | — | — | — |
ORIQUOrigin Investment Corp I Units | LTM Mar 2026 | $993.8K | — | — | — |
AFJKAimei Health Technology Co., Ltd | LTM Mar 2026 | $920.55K | -53.5% | — | — |
| LTM Mar 2026 | $586.98K | — | — | — | |
UYSCUY Scuti Acquisition Corp. | LTM Dec 2025 | $529.36K | — | — | — |
EURKEureka Acquisition Corp Class A Ordinary Share | LTM Mar 2026 | $451.93K | -65.0% | — | — |
| LTM Mar 2026 | $343.4K | -73.6% | — | — | |
| Peer median (excluding AFJK) | $586.98K | -65.0% | +5.1% | 13.1% | |
Competitors are the stored peer set for AFJK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Gross Margin | — | — | — |
| Research & Development | 0 | 0 | 0 |
| Selling, General & Admin | 28.46K | 0 | 835.76K |
| Operating Expenses | 28.46K | 1.07M | 835.76K |
| Depreciation & Amortization | 0 | 0 | 0 |
| EBITDA | 171.39K | (1.07M) | (835.76K) |
| EBITDA Margin | — | — | — |
| Operating Income | (28.46K) | (1.07M) | (835.76K) |
| Operating Margin | — | — | — |
| Interest Income | 199.85K | 3.62M | 1.9M |
| Interest Expense | 0 | 0 | 0 |
| Other Income / Expenses | 199.85K | 3.62M | 1.9M |
| Income Before Tax | 171.39K | 2.55M | 1.06M |
| Pre-Tax Margin | — | — | — |
| Income Tax Expense | 0 | 0 | 0 |
| Net Income | 171.39K | 2.55M | 1.06M |
| Net Margin | — | — | — |
| EPS (Basic) | 0.02 | 0.28 | 0.17 |
| EPS (Diluted) | 0.02 | 0.28 | 0.17 |
| Weighted Avg Shares | 9.03M | 9.03M | 4.05M |
| Weighted Avg Shares (Diluted) | 9.03M | 9.03M | 4.05M |
Aimei Health Technology Co., Ltd
NASDAQ:AFJK
Intrinsic Alpha fair value
Locked
Current Price
$11.96
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.